Young Nyun Park
Overview
Explore the profile of Young Nyun Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
296
Citations
7116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yim S, Lee S, Baek S, Sohn B, Jeong Y, Kang S, et al.
Clin Mol Hepatol
. 2025 Feb;
PMID: 40012401
No abstract available.
2.
Chung T, Oh S, Won J, Park J, Yoo J, Hwang H, et al.
J Hepatol
. 2025 Jan;
PMID: 39832657
Background & Aims: Papillary neoplasms of the biliary tree, including intraductal papillary neoplasms (IPNs) and intracholecystic papillary neoplasms (ICPNs), are recognized as precancerous lesions. However, the genetic characteristics underlying sequential...
3.
Burt A, Gouw A, Callea F, Clouston A, Dienes H, Goodman Z, et al.
Liver Int
. 2024 Dec;
45(1):e16196.
PMID: 39665793
No abstract available.
4.
Hur Y, Lee H, Yoo J, Park Y, Lee I, Bae Y
Free Radic Biol Med
. 2024 Dec;
227():246-259.
PMID: 39645205
There is growing evidence that NADPH oxidase 4 (Nox4) in hepatocytes contributes to liver inflammation and fibrosis during the development of metabolic dysfunction-associated steatohepatitis (MASH). However, how Nox4 is regulated...
5.
Jeon Y, Choi K, Park Y, Kim Y
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594773
Lung adenocarcinoma (LUAD) exhibits significant molecular heterogeneity; however, previous studies have not fully explored its classification into distinct molecular subtypes. Here, we identified LUAD-significant chromosomal instability (CIN) phenotype genes (...
6.
Rhee H, Park Y, Choi J
Korean J Radiol
. 2024 Sep;
25(10):887-901.
PMID: 39344546
Hepatocellular carcinoma (HCC) progresses through multiple stages of hepatocarcinogenesis, with each stage characterized by specific changes in vascular supply, drainage, and microvascular structure. These vascular changes significantly influence the imaging...
7.
Lee S, Kim M, Kim S, Han D, Choi G, Kim K, et al.
J Gastrointest Oncol
. 2024 Sep;
15(4):1796-1804.
PMID: 39279943
Background: Sarcomatoid change is rarely seen in epithelial malignancy that can be observed in diverse organs. Although a sarcomatoid change in combined hepatocellular-cholangiocarcinoma (cHCC-CC) is assumed to be a poor...
8.
Jang B, Kwon S, Kim J, Kim J, Chung T, Yoo J, et al.
Hepatol Commun
. 2024 Aug;
8(8).
PMID: 39101773
Background: Intermediate cell carcinoma (Int-CA) is a rare and enigmatic primary liver cancer characterized by uniform tumor cells exhibiting mixed features of both HCC and intrahepatic cholangiocarcinoma. Despite the unique...
9.
Yim S, Lee S, Baek S, Sohn B, Jeong Y, Kang S, et al.
Clin Mol Hepatol
. 2024 Jul;
30(4):807-823.
PMID: 39038962
Background/aims: Combination immunotherapy, exemplified by atezolizumab plus bevacizumab, has become the standard of care for inoperable hepatocellular carcinoma (HCC). However, the lack of predictive biomarkers and limited understanding of response...
10.
Soon G, Callea F, Burt A, Cook S, Terracciano L, Ercan C, et al.
Hum Pathol
. 2024 Jun;
149:55-65.
PMID: 38876199
Histological subtyping of hepatocellular carcinoma (HCC) is challenging in the presence of histological heterogeneity, where distinctly different morphological patterns are present within the same tumor. Current approaches rely on percent...